 Informed consenting patients will be randomised in two groups based on needle type. The traumatic group using Spinocan Quincke 22Gx3.5 needle and atraumatic group using Pencan Sprotte 22Gx3.5 needle. The randomisation process will be via an internet web-based application, provided by Norwegian university of science and Technology 